Page 94 - AN-1-2

Advanced Neurology Neurological complications of COVID-19

https://doi.org/10.1001/jama.2020.8391 https://doi.org/10.7759/cureus.18899
21. Pun BT, Badenes R, Heras G, et al., 2021, Prevalence and risk 32. Nasiri MJ, Haddadi S, Tahvildari A, et al., 2020, COVID-19
factors for delirium in critically ill patients with COVID-19 clinical characteristics, and sex-specific risk of mortality:
(COVID-D): A multicentre cohort study. Lancet Respir Med, Systematic review and meta-analysis. Front Med (Lausanne),
9(3): 239–250. 7: 459.
https://doi.org/10.1016/S2213-2600(20)30552-X https://doi.org/10.3389/fmed.2020.00459
22. Girard TD, Jackson JC, Pandharipande PP, et al., 2010, 33. Zhu J, Ji P, Pang J, et al., 2020, Clinical characteristics of 3062
Delirium as a predictor of long-term cognitive impairment in COVID-19 patients: A meta-analysis. J Med Virol, 92(10):
survivors of critical illness. Crit Care Med, 38(7): 1513–1520. 1902–1914.
https://doi.org/10.1097/CCM.0b013e3181e47be1 https://doi.org/10.1002/jmv.25884
23. Liu YH, Chen Y, Wang QH, et al., 2022, One-year trajectory 34. Huang C, Huang L, Wang Y, et al., 2021, 6-month
of cognitive changes in older survivors of COVID-19 in consequences of COVID-19 in patients discharged from
Wuhan, China: A longitudinal cohort study. JAMA Neurol, hospital: A cohort study. Lancet, 397(10270): 220–232.
79(5): 509–517. https://doi.org/10.1016/s0140-6736(20)32656-8
https://doi.org/10.1001/jamaneurol.2022.0461 35. van den Borst B, Peters JB, Brink M, et al., 2019,
24. Blomberg B, Mohn KG, Brokstad KA, et al., 2021, Long Comprehensive health assessment 3 months after recovery
COVID in a prospective cohort of home-isolated patients. from acute coronavirus disease 2019 (COVID-19). Clin
Nat Med, 27(9): 1607–1613. Infect Dis, 73(5): e1089–e1098.
https://doi.org/10.1038/s41591-021-01433-3 https://doi.org/10.1093/cid/ciaa1750
25. Yerlikaya D, Emek-Savaş DD, Kurşun BB, et al., 2018, 36. Ali AM, Kunugi H. 2021, Approaches to nutritional screening
Electrophysiological and neuropsychological outcomes in patients with coronavirus disease 2019 (COVID-19). Int J
of severe obstructive sleep apnea: Effects of hypoxemia on Environ Res Public Health, 18(5): 2772.
cognitive performance. Cogn Neurodyn, 12(5): 471–480. https://doi.org/10.3390/ijerph18052772
https://doi.org/10.1007/s11571-018-9487-z 37. Welch C, Greig C, Masud T, et al., 2020, COVID-19 and
26. Safavynia SA, Arora S, Pryor KO, et al., 2018, An update on acute sarcopenia. Aging Dis, 11(6): 1345–1351. https://doi.
postoperative delirium: Clinical features, neuropathogenesis, org/10.14336/AD.2020.1014
and perioperative management. Curr Anesthesiol Rep, 8(3): 38. Morley JE, Kalantar-Zadeh K, Anker SD. 2020, COVID:
252–262. A major cause of cachexia and sarcopenia? J Cachexia
27. Safavynia SA, Goldstein PA. 2019, The role of Sarcopenia Muscle, 11(4): 863–865.
neuroinflammation in postoperative cognitive dysfunction: https://doi.org/10.1002/jcsm.12589
Moving from hypothesis to treatment. Front Psychiatry,
9: 752. 39. Finsterer J, Scorza F. 2021, SARS-CoV-2 associated
rhabdomyolysis in 32 patients. Turk J Med Sci,
https://doi.org/10.3389/fpsyt.2018.00752 51(3): 1598–1601.
28. Cecchetti G, Agosta F, Canu E, et al., 2022, Cognitive, EEG, https://doi.org/10.3906/sag-2012-327
and MRI features of COVID-19 survivors: A 10-month
study. J Neurol, 269(7): 3400–3412. 40. Lorenzo RD, Conte C, Lanzani C, et al., 2020, Residual clinical
damage after COVID-19: A retrospective and prospective
https://doi.org/10.1007/s00415-022-11047-5 observational cohort study. PLoS One, 15(10): e0239570.
29. Hosp JA, Dressing A, Blazhenets G, et al., 2021, Cognitive 41. Geng Y, Ma Q, Du YS, et al., 2021, Rhabdomyolysis is
impairment and altered cerebral glucose metabolism in the associated with in-hospital mortality in patients with
subacute stage of COVID-19. Brain, 144(4): 1263–1276. COVID-19. Shock, 56(3): 360–367.
https://doi.org/10.1093/brain/awab009 https://doi.org/10.1097/SHK.0000000000001725
30. Liu K, Pan M, Xiao Z, et al., 2020, Neurological 42. Zhang Q, Schultz J, Aldridge G, Simmering J, et al., 2020,
manifestations of the coronavirus (SARS-CoV-2) pandemic Coronavirus disease 2019 case fatality and Parkinson’s
2019-2020. J Neurol Neurosurg Psychiatry, 91(6): 669–670. disease. Mov Disord, 35(11): 1914–1915.
https://doi.org/10.1136/jnnp-2020-323177 https://doi.org/10.1002/mds.28325
31. Ali L, Mohammed I, Janjua I, et al., 2021, Acute myocardial 43. Yaghi S, Ishida K, Torres J, et al., 2020, SARS2-CoV-2 and
injury and rhabdomyolysis in COVID-19 patients: Incidence stroke in a New York healthcare system. Stroke, 51(5):
and mortality. Cureus, 13(10): e18899. 2002–2011.

Volume 1 Issue 2 (2022) 8 https://doi.org/10.36922/an.v1i2.83